These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


197 related items for PubMed ID: 32278027

  • 1. MicroRNA-128-3p Alleviates Neuropathic Pain Through Targeting ZEB1.
    Zhang X, Zhang Y, Cai W, Liu Y, Liu H, Zhang Z, Su Z.
    Neurosci Lett; 2020 Jun 11; 729():134946. PubMed ID: 32278027
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. LINC00657 expedites neuropathic pain development by modulating miR-136/ZEB1 axis in a rat model.
    Shen F, Zheng H, Zhou L, Li W, Zhang Y, Xu X.
    J Cell Biochem; 2019 Jan 11; 120(1):1000-1010. PubMed ID: 30203524
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Circ_0005075 targeting miR-151a-3p promotes neuropathic pain in CCI rats via inducing NOTCH2 expression.
    Zhang Y, Gao T, Li X, Wen CC, Yan XT, Peng C, Xiao Y.
    Gene; 2021 Jan 30; 767():145079. PubMed ID: 32860901
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of microRNA-19a-3p alleviates the neuropathic pain (NP) in rats after chronic constriction injury (CCI) via targeting KLF7.
    Wang X, Pang J, Cui J, Liu A, Wang H.
    Transpl Immunol; 2023 Feb 30; 76():101735. PubMed ID: 36334791
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of MicroRNA-221 Alleviates Neuropathic Pain Through Targeting Suppressor of Cytokine Signaling 1.
    Xia L, Zhang Y, Dong T.
    J Mol Neurosci; 2016 Jul 30; 59(3):411-20. PubMed ID: 27059231
    [Abstract] [Full Text] [Related]

  • 17. LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial-to-mesenchymal transition by targeting miR-27b-3p and ZEB1 in diabetic nephropathy.
    Wang X, Xu Y, Zhu YC, Wang YK, Li J, Li XY, Ji T, Bai SJ.
    J Cell Physiol; 2019 Aug 30; 234(8):12926-12933. PubMed ID: 30549040
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-212-3p Attenuates Neuropathic Pain via Targeting Sodium Voltage-gated Channel Alpha Subunit 3 (NaV 1.3).
    Li Y, Zhang X, Fu Z, Zhou Q.
    Curr Neurovasc Res; 2019 Aug 30; 16(5):465-472. PubMed ID: 31713483
    [Abstract] [Full Text] [Related]

  • 19. miR-384-5p ameliorates neuropathic pain by targeting SCN3A in a rat model of chronic constriction injury.
    Ye G, Zhang Y, Zhao J, Chen Y, Kong L, Sheng C, Yuan L.
    Neurol Res; 2020 Apr 30; 42(4):299-307. PubMed ID: 32098588
    [Abstract] [Full Text] [Related]

  • 20. CRNDE enhances neuropathic pain via modulating miR-136/IL6R axis in CCI rat models.
    Zhang D, Mou JY, Wang F, Liu J, Hu X.
    J Cell Physiol; 2019 Dec 30; 234(12):22234-22241. PubMed ID: 31131445
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.